Scientific Services

  • Literature searches and reports with evidence based recommendations
  • Cost effectiveness models and Budget Impact Models
  • Scientific Platform slides and updates
  • All European and International regulatory work
  • AMCP dossier and updates
  • Core Value Dossier and Global Value Dossier
  • Standard Operating Procedure (SOP) and policy writing
  • Risk mitigation – review of SOPs and department policy
  • Freedom To Operate (FTO) searches
  • Value messages and updates
  • HTA medical writing
  • Lean 6-sigma process improvement and stop/go decisions
  • Attrition rate analysis – review of drugs in development by target class and mechanism of action
  • Competitor landscape analysis
  • Design of mechanism of action videos and Smartfone Apps
  • Strategy and tactical plans plus reviews

Payer Opinion for Reimbursement and Pharmacy 

  • Strategic advice about reimbursement and technology appraisals
  • New drug/device opinion on reimbursement
  • Recommended treatment pathways and algorithms

Therapy Area Expertise

  • Any work related to Systemic Lupus Erythematosus (SLE) including LUPUS reports, competitor landscape analyses and Scientific Platform – (strategy, CVD, AMCP)
  • CNS – mental health, analgesia
  • Monoclonal antibodies
  • Orphan diseases
  • Gastroenterology
  • All Autoimmune diseases

“A gateway to successful launch.”

Dr Sophia acted as Head of Market Access and Health Outcomes at Sucampo in 2015 and successfully completed two HTA submissions, in addition to supporting us with our value messages and medical writing…….we can thoroughly recommend her work.

Dr Peter Lichtlen, Chief Medical Officer, Sucampo Pharma Europe